N-myristoyltransferase 2 Inhibitors

N-myristoyltransferase 2 (NMT2) inhibitors are chemical compounds that target and inhibit the activity of the enzyme NMT2, a member of the N-myristoyltransferase family. NMT enzymes catalyze the covalent attachment of myristic acid, a 14-carbon saturated fatty acid, to the N-terminal glycine residue of substrate proteins in a process known as N-terminal myristoylation. This lipid modification is critical for protein-protein interactions, membrane targeting, and subcellular localization of various proteins. NMT2, one of two isoforms of this enzyme found in humans, plays a key role in regulating these post-translational modifications. Inhibition of NMT2 can lead to disruptions in protein function and localization due to the prevention of myristoylation, which can significantly alter cellular signaling pathways, protein stability, and membrane associations.

Chemically, NMT2 inhibitors are often small molecules designed to interfere with the enzyme's active site or its ability to bind myristoyl-CoA, the lipid substrate. These inhibitors typically have a high specificity for NMT2 over other proteins to avoid off-target effects that could result from indiscriminate myristoylation inhibition. The structure-activity relationship (SAR) of NMT2 inhibitors focuses on optimizing interactions with key residues in the enzyme's catalytic pocket while ensuring adequate binding affinity to prevent substrate processing. Moreover, structural features like lipophilicity, molecular weight, and hydrogen bonding capacity are considered when designing these inhibitors to ensure efficient penetration into cells, where they can exert their inhibitory effects on intracellular myristoylation processes. Understanding the mechanisms by which these inhibitors interact with NMT2 allows for deeper insight into cellular processes modulated by myristoylation and the potential for modulating protein activity at a biochemical level.